Expression of costimulatory molecules in human neuroblastoma. Evidence that CD40+neuroblastoma cells undergo apoptosis following interaction with CD40L

被引:31
作者
Airoldi, I
Lualdi, S
Bruno, S
Raffaghello, L
Occhino, M
Gambini, C
Pistoia, V
Corrias, M
机构
[1] Ist Giannina Gaslini, Lab Oncol, I-16148 Genoa, Italy
[2] Ist Giannina Gaslini, Serv Pathol, I-16148 Genoa, Italy
[3] Univ Genoa, Dept Expt Med, Sect Human Anat, Genoa, Italy
关键词
costimulatory molecules; human neuroblastoma; CD40; apoptosis; caspase-8;
D O I
10.1038/sj.bjc.6600951
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tumour cells display low to absent expression of costimulatory molecules. Here, we have investigated the expression of costimulatory molecules (CD40, CD80, CD86, PD-1L, B7H2, OX40L and 4-1BBL) in human neuroblastoma ( NB) cells, since virtually no information is available on this issue. Both established NB cell lines and primary tumours were tested by RT - PCR and flow cytometry. Neuroblastoma cell lines expressed the transcripts of all costimulatory molecule genes, but not the corresponding proteins. Culture of NB cell lines with human recombinant (r) IFN-gamma induced surface expression of CD40 in half of them. Primary NB cells showed CD40, CD80, CD86, OX40L, 4-1BBL, but not PD-1L and B7H2, mRNA expression. Surface CD40 was consistently detected on primary NB cells by flow cytometry. Interferon-gamma gene-transfected NB cells expressed constitutively surface CD40 and were induced into apoptosis by incubation with rCD40L through a caspase-8-dependent mechanism. CD40 may represent a novel therapeutic target in NB.
引用
收藏
页码:1527 / 1536
页数:10
相关论文
共 51 条
[1]   TRAIL-induced apoptosis of thyroid cancer cells: potential for therapeutic intervention [J].
Ahmad, M ;
Shi, YF .
ONCOGENE, 2000, 19 (30) :3363-3371
[2]   Characterization of human inducible costimulator ligand expression and function [J].
Aicher, A ;
Hayden-Ledbetter, M ;
Brady, WA ;
Pezzutto, A ;
Richter, G ;
Magaletti, D ;
Buckwalter, S ;
Ledbetter, JA ;
Clark, EA .
JOURNAL OF IMMUNOLOGY, 2000, 164 (09) :4689-4696
[3]   Expression and function of IL-12 and IL-18 receptors on human tonsillar B cells [J].
Airoldi, I ;
Gri, G ;
Marshall, JD ;
Corcione, A ;
Facchetti, P ;
Guglielmino, R ;
Trinchieri, G ;
Pistoia, V .
JOURNAL OF IMMUNOLOGY, 2000, 165 (12) :6880-6888
[4]  
Akiba H, 1999, J IMMUNOL, V162, P7058
[5]   Death receptors: Signaling and modulation [J].
Ashkenazi, A ;
Dixit, VM .
SCIENCE, 1998, 281 (5381) :1305-1308
[6]   Expression and methylation of CASP8 in neuroblastoma:: Identification of a promoter region [J].
Banelli, B ;
Casciano, I ;
Croce, M ;
Di Vinci, A ;
Gelvi, I ;
Pagnan, G ;
Brignole, C ;
Allemanni, G ;
Ferrini, S ;
Ponzoni, M ;
Romani, M .
NATURE MEDICINE, 2002, 8 (12) :1333-1335
[7]   INTERNATIONAL CRITERIA FOR DIAGNOSIS, STAGING, AND RESPONSE TO TREATMENT IN PATIENTS WITH NEURO-BLASTOMA [J].
BRODEUR, GM ;
SEEGER, RC ;
BARRETT, A ;
BERTHOLD, F ;
CASTLEBERRY, RP ;
DANGIO, G ;
DEBERNARDI, B ;
EVANS, AE ;
FAVROT, M ;
FREEMAN, AI ;
HAASE, G ;
HARTMANN, O ;
HAYES, FA ;
HELSON, L ;
KEMSHEAD, J ;
LAMPERT, F ;
NINANE, J ;
OHKAWA, H ;
PHILIP, T ;
PINKERTON, CR ;
PRITCHARD, J ;
SAWADA, T ;
SIEGEL, S ;
SMITH, EI ;
TSUCHIDA, Y ;
VOUTE, PA .
JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (12) :1874-1881
[8]  
Bugajska U, 2002, J NATL CANCER I, V94, P1381
[9]   4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy [J].
Cannons, JL ;
Lau, P ;
Ghumman, B ;
DeBenedette, MA ;
Yagita, H ;
Okumura, K ;
Watts, TH .
JOURNAL OF IMMUNOLOGY, 2001, 167 (03) :1313-1324
[10]   CTLA-4-mediated inhibition in regulation of T cell responses: Mechanisms and manipulation in tumor immunotherapy [J].
Chambers, CA ;
Kuhns, MS ;
Egen, JG ;
Allison, JP .
ANNUAL REVIEW OF IMMUNOLOGY, 2001, 19 :565-594